Skin and blood pharmacokinetics following 4 days of topical everyday dosing of Q-2361
| Timepoint following dosage | Concentration of Q-2361 in the skin (µg/g) | Concentration of Q-2361 in the blood (µg/mL) |
| 1 hour | 37.3±5.0 (n=2) | BLQ* |
| 6 hours | 52.3±2.0 (n=3) | BLQ |
Skin and whole-blood concentrations of Q-2361 expressed as mean±SD.
*One sample just above lower limit of quantitation (3.5 ng/mL).
BLQ, below the limit of quantitation.